Estadísticas de Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial

Visitas totales

views
Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial 0

Visitas totales por mes

views
noviembre 2023 0
diciembre 2023 0
enero 2024 0
febrero 2024 0
marzo 2024 0
abril 2024 0
mayo 2024 0